Reuters logo
BRIEF-Hunan Er-kang Pharmaceutical receives patent license from Canadian Intellectual Property Office
October 27, 2017 / 2:23 AM / in a month

BRIEF-Hunan Er-kang Pharmaceutical receives patent license from Canadian Intellectual Property Office

Oct 27 (Reuters) - Hunan Er-kang Pharmaceutical Co Ltd

* Says it received a patent license (No. 2872353), for the manufacturing method of membrane compound of soft capsule, from Canadian Intellectual Property Office

Source text in Chinese:goo.gl/chY3Yf

Further company coverage: (Beijing Headline News)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below